Sofinnova Ventures »

Moonlake Immunot shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $17M 293k 57.00

More positions owned by Sofinnova Ventures

Karuna Therapeutics Ord
Natera (NTRA)
AstraZeneca Sponsored Adr (AZN)
Merck & Co (MRK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Rayzebio
Dex (DXCM)
Aerovate Therapeutics (AVTE)
Intuitive Surgical (ISRG)
Vera Therapeutics Cl A (VERA)
Cytokinetics (CYTK)
Elanco Animal Health (ELAN)
IShares TR Russell 2000 Etf Put Option (IWM)
argenx SE Sponsored Adr (ARGX)
Exelixis Put Option (EXEL)

View all positions for Sofinnova Ventures

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
FMR
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Federated Investors
Darwin Global Management
Holocene Advisors
Westfield Capital Management Company
Alliancebernstein
Fred Alger Management
Balyasny Asset Management
BlackRock
Caption Management

View all funds holding Moonlake Immunot